ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Trevicta 263 mg/1.315 ml, Depot-Injektionssuspension in einer Fertigspritze - 
66054002 Janssen-Cilag AG
Trevicta 263 mg/1.315 ml, Depot-Injektionssuspension in einer Fertigspritze16.11.2016
  16.11.2016
Paliperidone (N05AX13) 
WHO-DDD 
01.05. 
01.05. 
B  
Yes 
IP 
938.22No
    
10 %1036.80
  
7680660540028Synthetika
6869615 
Composition
paliperidonum 263 mg ut paliperidoni palmitas 410 mg, polysorbatum 20, macrogolum 4000, acidum citricum monohydricum, natrii dihydrogenophosphas monohydricus, natrii hydroxidum, aqua ad iniectabile q.s. ad suspensionem pro 1.315 ml corresp. natrium 5.40 mg.
Packungsbestandteile
Retardsuspension zur intramuskulären Injektion 
  
 
Active AgentDose
Paliperidonum263mg / 1.315ml
BAG: Active AgentDose
Paliperidonum263 mg
 
Inactive agentsDose
Citric Acid Monohydrate 
Macrogol4000
Sodium Dihydrogenophosphate Monohydrate 
Sodium Hydroxide 
Polysorbatum 20 
 
Source
Data was imported : 06.11.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home